Interleukin-4 modulates the inflammatory response in ifosfamide-induced hemorrhagic cystitis

Inflammation

Volumn 35, Issue 1, 2012, Pages 297-307

  Macedo, Francisco Yuri Bulcão ^a   Mourão, Lívia Talita Cajaseiras ^a   Freitas, Helano Carioca ^a   Lima Jr , Roberto C P ^a   Wong, Deysi Viviana Tenazoa ^a   Oriá, Reinaldo Barreto ^a   Vale, Mariana L ^a   Brito, Gerly Anne Casto ^a   Cunha, Fernando Q ^b   Ribeiro, Ronaldo A ^a,c  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto do Cancer do Ceara   (Brazil)

Author keywords

Bladder; COX 2; Hemorrhagic cystitis; Ifosfamide; IL 1 ; IL 4; iNOS; TNF

Indexed keywords

CYCLOOXYGENASE 2; HOLOXANE; IFOSFAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESNA; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLADDER WET WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; HEMOGLOBIN DETERMINATION; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; CYCLOOXYGENASE 2; CYSTITIS; HEMORRHAGE; IFOSFAMIDE; INTERLEUKIN-1BETA; INTERLEUKIN-4; MALE; MESNA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER;

ANIMALIA; MUS;

EID: 84859430547     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9319-3     Document Type: Article

References (26)

1. Higgs, D., C. Nagy, and L.H. Einhorn. 1989. Ifosfamide: a clinical review. Seminars in Oncology Nursing 5: 70-77.
2. Dechant, K.L., R.N. Brogden, T. Pilkington, et al. 1991. Ifosfamide/ mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 42: 428-467.
3. Macedo, F.Y., F. Baltazar, L.C. Mourao, et al. 2008. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis. Experimental and Toxicologic Pathology 59: 425-430.
4. Brock, N., and J. Pohl. 1983. The development of mesna for regional detoxification. Cancer Treatment Reviews 10: 33-43. (Pubitemid 14249396)
5. Scheulen, M.E., N. Niederle, K. Bremer, et al. 1983. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II study with 151 patients. Cancer Treatment Reviews 10: 93-101. (Pubitemid 14249404)
6. Shulman, L.N. 1993. The biology of alkylating-agent cellular injury. Hematology/Oncology Clinics of North America 7: 325-335. (Pubitemid 23115856)
7. Vieira, M.M., G.A. Brito, J.N. Belarmino-Filho, F.Y. Macedo, et al. 2003. Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis. International Journal of Urology 10: 595-602. (Pubitemid 37506135)
8. Lima, M.V.A., F.V. Ferreira, F.Y.B. Macedo, and R.A. Ribeiro. 2007. Histological changes in bladders of patients submitted to ifosfamide based chemotherapy even with mesna prophylaxis. Cancer Chemotherapy and Pharmacology 59: 643-650. (Pubitemid 46295129)
9. Ribeiro, R.A., H.C. Freitas, M.C. Campos, et al. 2002. Tumor necrosis factor-α and interleukin-1 β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. Journal d'Urologie 176: 2229-2234. (Pubitemid 34309711)
10. Souza-Filho, M.V.P., M.V.A. Lima, M.M.L. Pompeu, et al. 1997. Involvement of nitric oxide in the pathogenesis of cyclophosphamide- induced hemorrhagic cystitis. The American Journal of Pathology 150: 247-256. (Pubitemid 27027114)
11. Macedo, F.Y., F. Baltazar, P.R. Almeida, F. Távora, F.V. Ferreira, F.C. Schmitt, G.A. Brito, and R.A. Ribeiro. 2008. Cyclooxygenase- 2 expression on ifosfamide-induced hemorrhagic cystitis in rats. Journal of Cancer Research and Clinical Oncology 134: 19-27. (Pubitemid 350064247)
12. Lord, C.J.M., and J.R. Lamb. 1996. TH2 cells in allergic inflammation: a target of immunotherapy. Clinical and Experimental Allergy 26: 756-765. (Pubitemid 26266420)
13. Tunon de Lara, J.M., Y. Okayama, A.R. Mceuen, et al. 1994. Release and inactivation of interleukin-4 by mast cells. Cells and cytokines in lung inflammation. Annals of the New York Academy of Sciences 725: 50-58.
14. Vannier, E., M.C. Miller, and C.A. Dinarello. 1992. Coordinated anti-inflammatory effects of interleukin4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proceedings of the National Academy of Science 89: 4076-4080.
15. Seitz, M., P. Loetscher, B. Dewald, H. Towbin, M. Ceska, and M. Baggiolini. 1994. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytesregulation by IFN-γ and IL-4. Journal of Immunology 152: 2060-2065. (Pubitemid 24075740)
16. Endo, T., F. Ogushi, and S. Saburo. 1996. LPS-dependent cyclooxygenase-2 induction in human monocytes is downregulated by IL-13, but not by IFN-γ. Journal of immunology 156: 2240-2246.
17. Malley, S.E., and M.A. Vizzard. 2002. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiological Genomics 9: 5-13. (Pubitemid 135707408)
18. Gray, K.J., U.H. Engelmann, E.H. Johnson, et al. 1986. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy. Journal d'Urologie 133: 497-500. (Pubitemid 16070487)
19. Hsu, S.M., and L. Raine. 1981. Protein A, avidin, and biotin in immunohistochemistry. The Journal of Histochemistry and Cytochemistry 29: 1349-1353. (Pubitemid 12231851)
20. Fenton, M.J., J.A. Buras, and R.P. Donelly. 1992. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. Journal of Immunology 149: 1283-1288.
21. Cunha, F.Q., S. Moncada, and F.Y. Liew. 1992. Interleukin-10 (IL- 10) inhibits the induction of nitric oxide synthase by interferongamma in murine macrophages. Biochemical and Biophysical Research Communications 182: 1155-1159.
22. Mota, J.M., G.A. Brito, R.T. Loiola, F.Q. Cunha, and R.A. Ribeiro. 2007. Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis. International Brazilian Journal of Urology 33: 704-710.
23. Trepicchio, W.L., M. Bozza, G. Pedneault, and A.J. Dorner. 1996. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Journal of Immunology 157: 3627-3634. (Pubitemid 126449177)
24. Smaldone, M.C., Y. Vodovotz, V. Tyagi, D. Barclay, B.J. Philips, N. Yoshimura, M.B. Chancellor, and P. Tyagi. 2009. Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide- induced cystitis. Urology 73(2): 421-426.
25. Nishisaka, F., S. Sohen, H. Fukuoka, Y. Okamoto, M. Matukawa, et al. 2001. Interleukin-4 reversed the interleukin-1-inhibited proteoglycan synthesis through the inhibition of NO release: a possible involvement of intracellular calcium ion. Pathophysiology 7(4): 289-293. (Pubitemid 32153807)
26. Hart, P.H., R.L. Cooper, and J.J. Finlay-Jones. 1991. IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages. Immunology 72(3): 344-349.